SERB Pharmaceuticals plans to buy Y-mAbs Pharmaceuticals in a $412 million all-cash deal. CorMedix bought Melinta ...

After a strong launch for its cancer gene therapy, Ferring Pharmaceuticals is setting the stage for long-term growth.

Jonathan D. Grinstein, PhD, Manfred Scholz, PhD, and Erik Wiklund, PhD, go behind the headlines to address a shifting policy landscape and what it means for the future of chronic disease, diagnostics, ...

Texas state Representative Mitch Little confessed the simple reality of his party’s sudden push for a new congressional map.

The National Weather Service has received permission to hire hundreds of employees, CNN reported Tuesday. That includes 450 ...

The number of biopharma professionals let go has increased year over year for three straight months. In July, nearly 8,000 ...

Seven Ohio companies reported 591 layoffs in June, per WARN Act notices filed with the state. Largest cuts came from Ohio ...

Allogene Therapeutics has reported a patient death tied to its anti-CD52 monoclonal antibody used for lymphodepletion in its ...

A biopharmaceutical research company with ties in Andover has laid off a third of its workforce as one of the industry leaders in gene therapy goes through a “strategic restructuring.” Sarepta ...

Alnylam Pharma raised its revenue outlook as its heart drug sees quick uptake.

The Food and Drug Administration’s polarizing vaccine chief is leaving the agency after a brief tenure that drew the ire of ...

Desai believes it's a "good time for fixed income," but wants to see more realistic investor expectations. Generations out there in the past got accustomed to getting just 1% -2.5% for investing in 10 ...